South Africa Medtech Reg: As New System Nears Finish Line, Device-Drug Distinctions Still Need Highlighting
Executive Summary
Stakeholders pushing for a dedicated medtech regulatory system in South Africa have been in sight of the finish line on several occasions in recent years, only for obstacles to rise. But a new structure is almost in place with the enactment of key rules this month. The country's device industry group, meanwhile, is still working to ensure the government fully appreciates important distinctions between devices and drugs.